Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Topiramate, Amitriptyline Monotherapy and Combination Therapy in Migraine Prophylaxis: An Open Label Randomized Clinical Trial

NCT05759845 is registered in ClinicalTrials.gov with Dr. Reaz Mahmud as lead sponsor.

NCT NCT05759845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05759845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Topiramate, Amitriptyline Monotherapy and Combination Therapy in Migraine Prophylaxis: An Open Label Randomized Clinical Trial
Lead sponsor
Dr. Reaz Mahmud
Phase
Phase 4
Overall status
Unknown status
Start date
August 22, 2022
Completion date
May 31, 2023
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine